The Senate Finance Committee on Thursday, April 23, held a subcommittee hearing on the impact of the medical device tax on jobs, innovation and patients. Since January 2013, manufacturers and importers of medical devices have faced a 2.3 percent excise tax to offset costs of the Affordable Care Act (ACA).